Clinical impact of antimicrobial resistance: design matters

Lancet Infect Dis. 2011 May;11(5):344; author reply 344-5. doi: 10.1016/S1473-3099(11)70107-4.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / therapeutic use
  • Bacteremia / drug therapy*
  • Bacteremia / microbiology
  • Bacteria / drug effects
  • Bacterial Infections / microbiology*
  • Bacterial Infections / prevention & control
  • Cross Infection / drug therapy
  • Cross Infection / microbiology*
  • Drug Resistance, Bacterial*
  • Humans
  • Intensive Care Units
  • Odds Ratio
  • Research Design / standards*
  • Risk Factors
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents